A. Gimelli, R. Liga et al. report on left ventricular (LV) mass determination using two commercially available softwares that they applied to cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), and compared results to cardiac magnetic resonance imaging (MRI) which was the reference standard. 1 For their study, they retrospectively identified n = 25 patients who underwent MPI with gated 99m Tc-tetrofosmin acquired on a CZT camera and had a cardiac MRI within 12 ± 3 weeks. To put the authors' work on LV mass determination in perspective, we will address the importance, accepted methods, and nuclear imaging approaches to LV mass measurement.A common cardiac adaptive mechanism in the setting of hemodynamic overload is the compensatory increase in LV mass, as explained by the Law of LaPlace in whichwhere s is the ventricular wall stress, P is the ventricular pressure, r is the ventricular radius, and T is the ventricular wall thickness. 2 However, this compensatory increase in ventricular wall thickness is detrimental on the long run, as demonstrated by multiple clinical studies. Indeed, an increase in LV wall thickness or mass, typically due to left ventricular hypertrophy (LVH), predicts an increased risk of cardiovascular morbidity and mortality as determined in the Framingham Heart Study, even after adjustment for major risk factors. 3 Moreover, the severity of LVH is an independent predictor of death and coronary revascularization. 4 These early observations have been confirmed by more contemporary data where LV mass and LVH were found to be predictive of the need for future revascularization, 5 and of the occurrence of myocardial infarction and cardiac death 6 in patients with or without stress-inducible ischemia 7 or in the setting of asymptomatic aortic stenosis. 8 In patients with a previous myocardial infarction, prognosis is related to the percentage of viable LV mass, and LV mass measurement can assess the development of compensatory focal LVH. 9 Quantification of LV mass is also useful in the evaluation and management of patients with valvular heart disease and hypertrophic cardiomyopathy. Further, LV mass has been demonstrated to predict the incidence of congestive heart failure in the Multi-Ethnic Study of Atherosclerosis. 10 In addition, assessment of LV mass can be used to monitor response to therapies such as weight reduction 11 or kidney transplantation. 12